Our Services
Medical Information
Helpful Resources
Published on: 10/6/2026
Transplant recipients face higher stakes with plague, including the strains sometimes linked to outbreaks in Russia and Central Asia, because lifelong immunosuppression can allow bubonic, septicemic, or pneumonic forms to progress faster and with vaguer early signs like fever, chills, swollen lymph nodes, or cough. Key points include avoiding rodents, fleas, and raw meat from endemic areas, seeking care within hours of symptoms, and knowing that first-line antibiotics such as fluoroquinolones and doxycycline can interact with tacrolimus, cyclosporine, and mTOR inhibitors, so drug levels and kidney function need monitoring. There are several important details, including post-exposure prophylaxis timing and when to contact your transplant team versus an emergency department, so see below to understand more before deciding what to do next.
Because immunosuppressed symptoms often look mild until they are not, it helps to organize what you are feeling quickly and clearly rather than waiting to see what happens. Take a free, instant, online symptom check to see which conditions may explain your symptoms and what step to take next.
Last reviewed for medical accuracy: 10/06/2026
Transplant recipients take medications that suppress the immune system. This raises both the risk of infection and the chance that a common illness can become severe. Although the “Russian plague” (a form of Yersinia pestis infection) remains rare, transplant patients should understand how to protect themselves, recognize warning signs, and seek prompt care.
Although most cases worldwide are bubonic and tied to flea bites on wild rodents, pneumonic plague can spread directly between people via droplets.
Transplant patients are considered immunocompromised. Key points:
Transplant patients should avoid all known routes of exposure:
Being proactive can greatly reduce risk:
Transplant recipients should stay vigilant for any unusual signs, no matter how mild:
If you develop any of these, especially after possible flea or animal exposure, act fast.
Transplant patients often worry about how plague antibiotics affect their anti-rejection therapy. To stay safe:
Your transplant team and infectious‐disease specialist should work closely to balance effective plague treatment with graft protection.
Reliable, up-to-date information helps you and your care team make sound decisions:
Even if you’re unsure whether your symptoms are serious, it’s better to err on the side of caution. You might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help gauge your situation. But remember:
By following these guidelines, you equip yourself to minimize risk, catch warning signs early, and secure the best possible outcome. Stay informed, stay prepared, and always reach out to your healthcare providers with any concerns.
(References)
* Cohen RG, Barr ML, Starnes VA. Pediatric lung transplantation. Semin Pediatr Surg. 1993 Nov;2(4):279-88. PMID: 8062048.
* Moake JL. Thrombotic thrombocytopenic purpura: the systemic clumping "plague". Annu Rev Med. 2002;53:75-88. doi: 10.1146/annurev.med.53.082901.103948. PMID: 11818464.
* Wolf DP, Kuo HC, Pau KY, Lester L. Progress with nonhuman primate embryonic stem cells. Biol Reprod. 2004 Dec;71(6):1766-71. doi: 10.1095/biolreprod.104.029413. Epub 2004 May 5. PMID: 15128597.
* Saraph V, Linhart WE. Modern treatment of pathological fractures in children. Injury. 2005 Feb;36 Suppl 1:A64-74. doi: 10.1016/j.injury.2004.12.015. PMID: 15652939.
* Bak M, Jacobson AS, Buchbinder D, Urken ML. Contemporary reconstruction of the mandible. Oral Oncol. 2010 Feb;46(2):71-6. doi: 10.1016/j.oraloncology.2009.11.006. Epub 2009 Dec 29. PMID: 20036611.
* Wang H, Zhou J, Liu Z, Wang C. Injectable cardiac tissue engineering for the treatment of myocardial infarction. J Cell Mol Med. 2010 May;14(5):1044-55. doi: 10.1111/j.1582-4934.2010.01046.x. Epub 2010 Feb 27. PMID: 20193036; PMCID: PMC3822739.
* Tang C, Russell PJ, Martiniello-Wilks R, Rasko JE, Khatri A. Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? Stem Cells. 2010 Sep;28(9):1686-702. doi: 10.1002/stem.473. PMID: 20629172; PMCID: PMC2996089.
* Longo UG, Loppini M, Berton A, La Verde L, Khan WS, Denaro V. Stem cells from umbilical cord and placenta for musculoskeletal tissue engineering. Curr Stem Cell Res Ther. 2012 Jul;7(4):272-81. doi: 10.2174/157488812800793054. PMID: 22563663.
* Navva PK, Venkata Sreepada S, Shivanand Nayak K. Present Status of Renal Replacement Therapy in Asian Countries. Blood Purif. 2015;40(4):280-7. doi: 10.1159/000441574. Epub 2015 Nov 17. PMID: 26656132.
* Fakoya AO. New Delivery Systems of Stem Cells for Vascular Regeneration in Ischemia. Front Cardiovasc Med. 2017;4:7. doi: 10.3389/fcvm.2017.00007. Epub 2017 Feb 24. PMID: 28286751; PMCID: PMC5323391.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.